TCF3
Transcription factor E2-alpha
Also known as: bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, TFE2_HUMAN, VDIR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15923
- Gene
- TCF3
- Ensembl
- ENSG00000071564
- Chromosome
- 19
- Canonical length
- 654 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1;19), with PBX1), childhood leukemia (t(19;19), with TFPT) and acute leukemia (t(12;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
654 residues, UniProt reviewed canonical sequence.
>P15923|TCF3
1 MNQPQRMAPV GTDKELSDLL DFSMMFPLPV TNGKGRPASL AGAQFGGSGL EDRPSSGSWG
61 SGDQSSSSFD PSRTFSEGTH FTESHSSLSS STFLGPGLGG KSGERGAYAS FGRDAGVGGL
121 TQAGFLSGEL ALNSPGPLSP SGMKGTSQYY PSYSGSSRRR AADGSLDTQP KKVRKVPPGL
181 PSSVYPPSSG EDYGRDATAY PSAKTPSSTY PAPFYVADGS LHPSAELWSP PGQAGFGPML
241 GGGSSPLPLP PGSGPVGSSG SSSTFGGLHQ HERMGYQLHG AEVNGGLPSA SSFSSAPGAT
301 YGGVSSHTPP VSGADSLLGS RGTTAGSSGD ALGKALASIY SPDHSSNNFS SSPSTPVGSP
361 QGLAGTSQWP RAGAPGALSP SYDGGLHGLQ SKIEDHLDEA IHVLRSHAVG TAGDMHTLLP
421 GHGALASGFT GPMSLGGRHA GLVGGSHPED GLAGSTSLMH NHAALPSQPG TLPDLSRPPD
481 SYSGLGRAGA TAAASEIKRE EKEDEENTSA ADHSEEEKKE LKAPRARTSP DEDEDDLLPP
541 EQKAEREKER RVANNARERL RVRDINEAFK ELGRMCQLHL NSEKPQTKLL ILHQAVSVIL
601 NLEQQVRERN LNPKAACLKR REEEKVSGVV GDPQMVLSAP HPGLSEAHNP AGHMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 78 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 78 nTPM
- bone marrow: 65 nTPM
- thymus: 62 nTPM
- tonsil: 56 nTPM
- testis: 51 nTPM
- spleen: 44 nTPM
Single-cell type
- erythrocyte progenitors: 129 nCPM
- undifferentiated spermatogonia: 119 nCPM
- plasma cells: 96 nCPM
- b-cells: 74 nCPM
- thymocytes: 65 nCPM
- megakaryocyte-erythroid progenitors: 57 nCPM
Immune cell
- plasmacytoid DC: 13 nTPM
- naive B-cell: 11 nTPM
- memory B-cell: 9.9 nTPM
- naive CD8 T-cell: 4.3 nTPM
- MAIT T-cell: 3.7 nTPM
- gdT-cell: 3.4 nTPM
Brain region
- medulla oblongata: 29 nTPM
- choroid plexus: 28 nTPM
- white matter: 28 nTPM
- cerebral cortex: 27 nTPM
- amygdala: 26 nTPM
- pons: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCF3.
Disease | AllUniProt
Conditions TCF3 is implicated in, by any mechanism.
- Agammaglobulinemia 8A, autosomal dominant (AGM8A) MIM:616941
- Agammaglobulinemia 8B, autosomal recessive (AGM8B) MIM:619824
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 1,207 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Agammaglobulinemia 8, autosomal dominant
- Agammaglobulinemia 8b, autosomal recessive
- Inborn genetic diseases
- Multiple myeloma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.03
- gnomAD missense Z
- -0.23
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- B cell lineage commitment
- immunoglobulin V(D)J recombination
- negative regulation of transcription by RNA polymerase II
- nervous system development
- positive regulation of B cell proliferation
- positive regulation of cell cycle
- positive regulation of DNA-binding transcription factor activity
- positive regulation of DNA-templated transcription
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of G1/S transition of mitotic cell cycle
- regulation of transcription by RNA polymerase II
Molecular functions
- bHLH transcription factor binding
- cis-regulatory region sequence-specific DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- E-box binding
- mitogen-activated protein kinase kinase kinase binding
- protein heterodimerization activity
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- vitamin D response element binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCF3 as an antibody target. Whether an autoantibody or antibody against TCF3 could matter depends on whether native TCF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...